These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10850398)

  • 1. Diurnal changes in the pharmacokinetic behavior of amikacin.
    Bleyzac N; Allard-Latour B; Laffont A; Mouret J; Jelliffe R; Maire P
    Ther Drug Monit; 2000 Jun; 22(3):307-12. PubMed ID: 10850398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
    Pivot-Dumarest C; Deweerdt C; Troncy J; Sorensen P; Roux D; Maire P
    Pathol Biol (Paris); 1996 Apr; 44(4):299-305. PubMed ID: 8763595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individual variability of pharmacokinetic parameters of amikacin in the elderly: retrospective studies].
    Vincent S; Maire PH; Bataillard T; Denjean E; Ducrozet P; Laffont A; Visent C; Jelliffe RW
    Pathol Biol (Paris); 1996 Sep; 44(7):667-74. PubMed ID: 8977923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation.
    Bleyzac N; Varnier V; Labaune JM; Corvaisier S; Maire P; Jelliffe RW; Putet G; Aulagner G
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):499-504. PubMed ID: 11699615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and renal toxicity of three once-a-day doses of amikacin in cows.
    Sumano H; Gutierrez L; Velazquez C; Hayashida S
    Acta Vet Hung; 2005; 53(2):231-40. PubMed ID: 15959981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic analysis of amikacin twice and single daily dosage in immunocompromised pediatric patients.
    Krivoy N; Postovsky S; Elhasid R; Ben Arush MW
    Infection; 1998; 26(6):396-8. PubMed ID: 9861567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Favereau JP; Gay R
    Int J Biomed Comput; 1994 Jun; 36(1-2):135-7. PubMed ID: 7927853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of unilateral nephrectomy on the pharmacokinetics of amikacin in humans.
    Drozdzik M; Domanski L; Wojcicki J; Gawronska-Szklarz B; Machoy P; Pudlo A
    J Pharm Pharmacol; 2002 Apr; 54(4):509-14. PubMed ID: 11999128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
    Petitcollin A; Dequin PF; Darrouzain F; Vecellio L; Boulain T; Garot D; Paintaud G; Ternant D; Ehrmann S
    J Antimicrob Chemother; 2016 Dec; 71(12):3482-3486. PubMed ID: 27516474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic variability of amikacin after once-daily and twice-daily dosing regimen in full-term neonates.
    Vučićević K; Rakonjac Z; Miljković B; Janković B; Prostran M
    J Pharmacol Sci; 2014; 124(2):138-43. PubMed ID: 24441865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
    Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O
    Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of renal function equations to predict amikacin clearance.
    Sáez Fernández EM; Pérez-Blanco JS; Lanao JM; Calvo MV; Martín-Suárez A
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):805-813. PubMed ID: 31242039
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients.
    Vic P; Ategbo S; Turck D; Husson MO; Tassin E; Loeuille GA; Deschildre A; Druon D; Elian JC; Arrouet-Lagandre C; Farriaux JP
    Eur J Pediatr; 1996 Nov; 155(11):948-53. PubMed ID: 8911895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of infusion method on amikacin serum levels in humans.
    Simon N; Décaudin B; Lannoy D; Odou MF; De Broucker M; Barthélémy C; Poret E; Dubreuil L; Odou P
    Pulm Pharmacol Ther; 2010 Aug; 23(4):324-6. PubMed ID: 20307680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuation of the volume of distribution of amikacin and its effect on once-daily dosage and clearance in a seriously ill patient.
    Botha FJ; van der Bijl P; Seifart HI; Parkin DP
    Intensive Care Med; 1996 May; 22(5):443-6. PubMed ID: 8796397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.